Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
INTRODUCTION: Cerebral small vessel disease is a leading cause of functional loss, disability, and cognitive impairment. OBJECTIVE: To determine the prevalence of small vessel disease and clinical characteristics associated with greater functional, cognitive and affective impairment in older adults with cerebrovascular disease at-tended at the Neurology Service of the Carlos Andrade Marín Hospital in the period 2020 - 2021. METHODOLOGY: Observational, analytical cross-sectional study with 80 patients over 65 years of age with previously diagnosed cerebrovascular disease. It was determined which patients had cerebral small vessel disease. The two groups of ischemic cerebrovascular disease with and without cerebral small vessel disease
were compared. The degree of functional impairment was measured with the Barthel, Lawton and Brody scales. Cognitive impairment was measured with the Montreal Cognitive Assessment-Basic test, and affective state with the Yesavage scale. Odds ratio was used and a p value <0,05 was considered significant. Statistical Package for Social Sciences version 25 was used. RESULTS: Males represented 51,2%. Mean age
was 76,2 years. Prevalence of cerebral small vessel disease (87,5%). Fazekas scale grade 1 (46,3%), Factors associated with cerebral small vessel disease: smoking [RR: 7,27; 95% CI: 1,69-31,3); chronic kidney disease [RR: 4,0; 95% CI: 1,01-15,7]. Mode-rate dependence [RR: 6,42; 95% CI: 1,02-40,3]. Factors associated with loss of function: severity of stroke. Factors associated with cognitive impairment: infarction with double territory. Factors associated with affective impairment: dual territory infarction and metabolic syndrome (p<0.05). CONCLUSION: Cerebral small vessel disease has a high prevalence among older adults with cerebrovascular disease and represented a considerable cognitive, functional and affective deterioration, in relation to patients without this disease.
Aranco N, Stampini M, Ibarrarán P, Medellín N. Panorama de envejecimiento y dependencia en América
Latina y el Caribe. 2018. Available from:
https://publications.iadb.org/handle/11319/8757
Núñez S, Duplat A, Simancas D. Mortality due to cerebrovascular diseases in Ecuador 2001- 2015: a trend
study, application of the joinpoint regression model. Rev Ecuat Neurol. 2018;27(1):16–22. Available from:
Moreno D, Santamaría D, Ludeña C, Barco A, Vázquez D. Enfermedad Cerebrovascular en el Ecuador: Análisis
de los Últimos 25 Años de Mortalidad, Realidad Actual y Recomendaciones - revecuatneurol - Revista Ecuato-
riana de Neurología. Rev Ecuat Neurol. 2016;25(3):56–9. Available from:
Instituto Nacional de Estadística y Censos. Estadísticas Vitales. 2016. INEC. Disponible en:
Cannistraro R, Badi M, Eidelman B, Dickson D, Middlebrooks E, Meschia J. CNS small vessel disease. Neu-
rology [Internet]. 2019;92(24):1146–56. Available from:
https://n.neurology.org/content/92/24/1146
Van Middelaar T, Argillander T, Schreuder F, Deinum J, Richard E, Klijn C. Effect of Antihypertensive Me-
dication on Cerebral Small Vessel Disease. Stroke. 2018;49(6):1531–3. Available from:
https://www.aha-journals.org/doi/abs/10.1161/STROKEAHA.118.021160
The LADIS Study Group. 2001–2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What
Have We Learned about White Matter Changes and Small-Vessel Disease? Cerebrovasc Dis. 2011;32(6):577–88.
Available from:
https://www.karger.com/Article/Full-Text/334498
Ikram M, Van der Lugt A, Niessen W, Koudstaal P, Krestin G, Hofman A, et al. The Rotterdam Scan Study:
design update 2016 and main findings. Eur J Epidemiol 2015; 30 (12): 1299–315. Available from:
https://link.springer.com/article/10.1007/s10654-015-0105-7
Shi Y, Wardlaw JM. Update on cerebral small vessel disease: a dynamic whole-brain disease. Stroke Vasc
Neurol. 2016;1(3):83–92. Available from:
https://svn.bmj.com/content/1/3/83
Matić T, Toncev G, Gavrilović A, Aleksić D. Suffering from cerebral small vessel disease with and without
metabolic syndrome. Open Med. 2019;14(1):479–84. Available from:
https://www.degruyter.com/document/doi/10.1515/med-2019-0051/html
Han F, Zhai FF, Wang Q, Zhou LX, Ni J, Yao M, et al. Prevalence and Risk Factors of Cerebral Small Vessel Di-
sease in a Chinese Population-Based Sample. J Stroke. 2018;20(2):239–46. Available from:
http://j-stroke.org/journal/view.php?doi=10.5853/jos.2017.02110
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for
research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol [Internet]. 2013 Aug;12(8):822–38. Available from:
https://linkinghub.elsevier.com/retrieve/pii/S1474442213701248
Mahoney F, Barthell D. Functional evaluation: The Barthel Index. Md State Med J [Internet]. 1965
Feb;14(2):61–5. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/14258950
Lawton M, Brody E. Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily
Living. Gerontologist [Internet]. 1969 Sep 1;9(3 Part 1):179– 86. Available from: https://academic.oup.com/gerontologist/article-lookup/doi/10.1093/geront/9.3_Part_1.179
Yesavage J, Brink T, Rose T, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depres-
sion screening scale: A preliminary report. J Psychiatr Res. 1982;17(1):37–49. Available from: https://linkinghub.else-vier.com/retrieve/pii/0022395682900334
Nasreddine Z, Phillips N, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive As-
sessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15817019
Wahlund L, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, et al. A New Rating Scale for Age-Related
White Matter Changes Applicable to MRI and CT. Stroke. 2001;32(6):1318–22. Available from: https://www.ahajour-nals.org/doi/10.1161/01.STR.32.6.1318
National Institute for Neurological Disorders and Stroke. NIH Stroke Scale. 2003. Available from: https://www.ninds.nih.gov/health-information/public-education/know-stroke/health-professionals/nih-stroke-scale
Brenner A, Burke J, Skolarus L. Moving Toward an Unerstanding of Disability in Older U.S. Stroke Survivors.
J Aging Health. 2018;30(1):75–104. Available from:
http://journals.sagepub.com/doi/10.1177/0898264316666125
Guzik A, Bushnell C. Stroke Epidemiology and Risk Factor Management. Contin Lifelong Learn Neurol.
;23(1):15–39. Available from: https://pubmed.ncbi.nlm.nih.gov/28157742/
Muratova T, Khramtsov D, Stoyanov A, Vorokhta Y. Clinical epidemiology of ischemic stroke: global
trends and regional differences. Georgian Med News. 2020;5(299):83–6. Available from:
https://pubmed.ncbi.nlm.nih.gov/32242851/
Barbay M, Taillia H, Nedelec-Ciceri C, Arnoux A, Puy L, Wiener E, et al. Vascular cognitive impairment: Advances and trends. Rev Neurol. 2017;173(7–8):473–80. Available from: https://pubmed.ncbi.nlm.nih.gov/28838792/
Schmidt R, Seiler S, Loitfelder M. Longitudinal change of small-vessel disease-related brain abnormalities. J Cereb Blood Flow Metab. 2016;36(1):26–39. Available from:
http://journals.sagepub.com/doi/10.1038/jcbfm.2015.72
Hilal S, Mok V, Youn YC, Wong A, Ikram MK, Chen CL hsian. Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries. J Neurol Neurosurg Psychiatry. 2017;88(8):669–74. Available from:
https://jnnp.bmj.com/lookup/doi/10.1136/jnnp2016-315324
Clancy U, Appleton JP, Arteaga C, Doubal FN, Bath PM, Wardlaw JM. Clinical management of cerebral small vessel disease: a call for a holistic approach. Chin Med J (Engl). 2021;134(2):127–42. Available from: https://journals.lww.com/10.1097/CM9.0000000000001177
Zhou L, Panenka W, Al-Momen G, Gicas K, Thornton A, Jones A, et al. Cerebral Small Vessel Disease, Risk Factors, and Cognition in Tenants of Precarious Housing. Stroke. 2020;51(11):3271–8. Available from: https://pubmed.ncbi.nlm.nih.gov/33019899/
Teng Z, Dong Y, Zhang D, An J, Lv P. Cerebral small vessel disease and post-stroke cognitive impairment. Int
J Neurosci. 2017;127(9):824–30. Available from:
https://www.tandfonline.com/doi/full/10.1080/00207454.2016.1261291
Dichgans M, Wardlaw J, et al. METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research. Alzheimer’s Dement [Internet]. 2016;12(12):1235–49. Available from:
https://alz-journals.onlinelibrary.wiley.com/doi/10.1016/j.jalz.2016.06.004
Jeon J, Jeong H, Choi D, Ham Y, Na K, Lee K, et al. Prognostic Relationships between Microbleed, Lacunar Infarction, White Matter Lesion, and Renal Dysfunction in Acute Ischemic Stroke Survivors. J Stroke Cerebrovasc Dis [Internet]. 2017;26(2):385–92. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1052305716303688
Kim B, Lee S. Prognostic Impact of Cerebral Small Vessel Disease on Stroke Outcome. J Stroke [Internet].
;17(2):101–10. Available from:
https://pubmed.ncbi.nlm.nih.gov/26060797/
Douven E, Staals J, Freeze W, Schievink S, Hellebre-kers D, Wolz R, et al. Imaging markers associated with
the development of post-stroke depression and apathy: Results of the Cognition and Affect after Stroke – a Pros-
pective Evaluation of Risks study. Eur Stroke J [Internet]. 2020;5(1):78–84. Available from: https://pubmed.ncbi.nlm.nih.gov/32232173/
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.
